Revenue grew 8% YoY to €3.4m, driven by Lifecare's strong performance and Wellness's return to profitability. RTM launched in the US, and a non-dilutive share buyback was initiated. Management expects accelerated ARR growth in H2 2026.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.